These new drugs, including Rybelsus, are belonging to a category of treatments called GLP-1 receptor agonists. Essentially, GLP-1 is a body's own chemical that assists regulate glucose levels and promotes feelings of fullness, potentially can lead to weight management. Semaglutide is a particular type of this GLP-1 drug and is typically used for co